Man Group plc Acquires Shares of 135,584 Phreesia, Inc. $PHR

Man Group plc acquired a new position in Phreesia, Inc. (NYSE:PHR) in the second quarter, Holdings Channel reports. The institutional investor acquired 135,584 shares of the company’s stock, valued at approximately $1,395,000.

A number of other large investors have also recently made changes to their positions in the business. Van ECK Associates Corp raised its position in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after buying an additional 1,102 shares in the last quarter. Rockefeller Capital Management L.P. grew its position in Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares during the last quarter. Garner Asset Management Corp bought a new stake in Phreesia during the fourth quarter worth approximately $81,000. Finally, New York State Teachers Retirement System purchased a new stake in Phreesia during the first quarter valued at approximately $44,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Stock Up 0.3%

Shares of NYSE:PHR opened at $11.88 on Thursday. Phreesia, Inc. has a 1 year low of $7.77 and a 1 year high of $31.83. The business has a 50 day simple moving average of $11.19 and a two-hundred day simple moving average of $10.48. The firm has a market capitalization of $734.30 million, a PE ratio of 79.20 and a beta of 0.86. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The business had revenue of $129.46 million for the quarter, compared to the consensus estimate of $129.06 million. During the same period in the prior year, the company posted $0.01 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, equities analysts predict that Phreesia, Inc. will post 0.39 EPS for the current year.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia generated positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, strengthening its balance sheet and supporting profitability expansion. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with the $515 million analyst consensus, reducing the risk of a near-term outlook cut. The company also identified AccessOne as a potential multi-year growth driver. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Needham & Company issued a Buy rating, providing favorable analyst support for PHR following the earnings release. Phreesia Earns Buy Rating from Needham
• Neutral Sentiment: Revenue reached $129.46 million, up 10.4% year over year and slightly above the $129.06 million consensus estimate, indicating continued growth but not a major top-line upside surprise. Phreesia fiscal second-quarter results
• Negative Sentiment: Quarterly EPS was $0.03, below analyst expectations of approximately $0.09 to $0.11, although it improved from $0.01 in the prior-year quarter. The earnings shortfall may weigh on investor sentiment despite the company’s cash-flow progress. Phreesia Q2 earnings and revenues lag estimates

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $9.00 price objective (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. DA Davidson reissued a “buy” rating and set a $14.00 target price on shares of Phreesia in a research report on Thursday, May 28th. Needham & Company LLC restated a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research report on Monday. Weiss Ratings raised shares of Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, July 20th. Finally, Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Nine research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Phreesia has an average rating of “Hold” and a consensus price target of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.